SHARE
COPY LINK

MALARIA

Malaria victim told to pay France back €87,000

A young Frenchman who fell into a coma after contracting malaria in Africa has been told that he owes France €87,000 for his life-saving treatment and repatriation. His family has called on the French public to help foot the bill.

Malaria victim told to pay France back €87,000
Matthieu Jacquet, 28-year-old Frenchman and malaria survivor. Photo: Facebook
Matthieu Jacquet, 28, was unemployed and looking for work in eastern Africa's Malawi back in April. However, after falling violently ill, he was diagnosed with malaria and fell into a coma.
 
Needing urgent medical treatment and with his insurance having run out, his family was told that a medically supervised flight back to Paris would cost €250,000. 
 
They eventually opted for the cheaper option of a flight to the French island of Réunion in the Indian ocean, which still cost €87,000.
 
The man's sister, Magali, told The Local that without signing an acknowledgement of the debt, the plane would not have taken off.
 
“He didn't have a choice to be repatriated, he was dying,” she said. 
 
The trainee pastry chef recovered after spending nine days in a coma and a “three-week blackout”, only to be faced by the colossal bill which has to be paid by September 15th. 
 

(Photo: Facebook)
 
And his family is outraged. 
 
“I'm not disappointed with the government – I am sickened,” Matthieu's sister said. 
 
She added that while her brother was between jobs, he was not notified that he would not be insured by his new employers.
 
She also added that he wasn't taking malaria medication at the time, as he had already suffered from the illness the previous year and was deemed to have been cured.
 
Now, with the family unable to repay the debt, Magali has taken charge of launching an online petition in an effort to get the government to cancel the debt. It has garnered over 5,000 signatures since it was created on Tuesday.
 
The family has also asked the public to make donations in an effort to help chip away at the invoice. So far, around €4,000 has been raised. 
 
On top of this, Magali is spearheading a Facebook group in order to raise awareness, where over 1,000 people have followed to share their support.
 
“Another absurdity from this crap government, it disgusts me,” one follower wrote. 
 
The cover picture shows a black background with the words “Je Suis Matthieu”, a reference to the “Je Suis Charlie” slogan that gained worldwide recognition after the January terror attacks at the Charlie Hebdo newspaper in Paris.
 

(Malawi in south-eastern Africa. Photo: GoogleMaps)
 
But not everyone is supportive of the cause. One Facebook user, Mark Hornblower, wrote on the group's wall: 
 
“What a stupid idea to go to work as a chef in Malawi (…) It's lucky that he is repatriated now, safe and sound, but you can't ask taxpayers to pay for his bullshit.”
 
Some officials have also taken sides, some quick to note that while insurance may not be mandatory, it is recommended.
 
“The French mistakenly think the state will take care of everything if any problems arise,” Charlotte Hemery, communications manager at the Union for French Nationals Abroad (UFE), told Le Figaro newspaper.
 
“It's up to the traveller to take out insurance to help out with incidents like this.”
 
 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

SANOFI

French firm signals ‘new era’ in malaria fight

French pharmaceutical giant Sanofi has signalled the start of a "new era" in the fight against malaria by announcing the development of a new form of anti-malaria drug, which will be shipped to Africa in the coming months.

French firm signals 'new era' in malaria fight
Frencg drugs giant Sanofi has signalled a new era in fight against malaria. Photo: CDC/Flickr

French pharmaceutical giant Sanofi announced on Tuesday the delivery of the first anti-malaria drugs using a semi-synthetic version of their key ingredient to millions of patients in Africa.

Sanofi said that the development of semi-synthetic artemisinin – the weapon of choise against malaria – signalled a "new era" in the fight against the mosquito-borne disease.

Artemisinin is normally derived from a plant called sweet wormwood, but the weather can affect harvests of the plant, causing shortages and price spikes.

The drugmaker said it had been able to make 1.7 million treatments with the semi-synthetic alternative, which will be shipped to Burkina Faso, Burundi, Democratic Republic of the Congo, Liberia, Niger, and Nigeria in the coming months.

The World Health Organization gave the use of semi-synthetic artemisinin in malaria products the green light in May last year.

Sanofi said that "by complementing botanically-derived supplies, the new option can widen access to treatment for millions sickened by malaria every year."

According to the WHO's last malaria report, published last December, the disease killed 627,000 people in 2012, mainly children in Africa, with an estimated 207 million cases worldwide.

SHOW COMMENTS